Education
About Us
Working with TipRanks
Follow Us
Impact BioMedical, Inc. (IBO)
:IBO
Total Valuation
Impact BioMedical, Inc. has a market cap or net worth of ―. The enterprise value is $23.42M.
Market Cap―
Enterprise Value$23.42M
Share Statistics
Impact BioMedical, Inc. has 12,085,412 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,085,412
Owned by Insiders0.81%
Owned by Institutions0.15%
Financial Efficiency
Impact BioMedical, Inc.’s return on equity (ROE) is -0.24 and return on invested capital (ROIC) is -8.00%.
Return on Equity (ROE)-0.24
Return on Assets (ROA)-0.15
Return on Invested Capital (ROIC)-8.00%
Return on Capital Employed (ROCE)-0.09
Revenue Per Employee535.40K
Profits Per Employee-5.25M
Employee Count2
Asset Turnover<0.01
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of Impact BioMedical, Inc. is -3.88K. Impact BioMedical, Inc.’s PEG ratio is 0.00.
PE Ratio-3.88K
PS Ratio0.00
PB Ratio722.43
Price to Fair Value926.61
Price to FCF-30.48K
Price to Operating Cash Flow-30.48K
PEG Ratio0.00
Income Statement
In the last 12 months, Impact BioMedical, Inc. had revenue of 1.07M and earned -10.50M in profits. Earnings per share was -0.06.
Revenue1.07M
Gross Profit1.07M
Operating Income497.15K
Pretax Income-10.50M
Net Income-10.50M
EBITDA-4.61M
Earnings Per Share (EPS)-0.06
Cash Flow
In the last 12 months, operating cash flow was -2.82M and capital expenditures -408.54K, giving a free cash flow of -3.22M billion.
Operating Cash Flow-2.82M
Free Cash Flow-3.22M
Free Cash Flow per Share-0.27
Dividends & Yields
Impact BioMedical, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta3.54
52-Week Price Change-80.69%
50-Day Moving Average0.51
200-Day Moving Average―
Relative Strength Index (RSI)41.39
Average Volume (3m)691.46K
Important Dates
Impact BioMedical, Inc. upcoming earnings date is ―, TBA Not Confirmed.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Impact BioMedical, Inc. as a current ratio of 0.01, with Debt / Equity ratio of 2.79%
Current Ratio0.01
Quick Ratio0.01
Debt to Market Cap<0.01
Net Debt to EBITDA-4.36
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Impact BioMedical, Inc. has paid -59.80K in taxes.
Income Tax-59.80K
Effective Tax Rate-0.08
Enterprise Valuation
Impact BioMedical, Inc. EV to EBITDA ratio is -11.96K, with an EV/FCF ratio of -10.88K.
EV to Sales547.95K
EV to EBITDA-11.96K
EV to Free Cash Flow-10.88K
EV to Operating Cash Flow-12.22K
Balance Sheet
Impact BioMedical, Inc. has $353.05K in cash and marketable securities with C$2.65M in debt, giving a net cash position of $2.30M billion.
Cash & Marketable Securities$353.05K
Total DebtC$2.65M
Net Cash$2.30M
Net Cash Per Share$0.19
Tangible Book Value Per Share-$0.18
Margins
Gross margin is 0.00%, with operating margin of -6808.00%, and net profit margin of -14102.00%.
Gross Margin0.00%
Operating Margin-6808.00%
Pretax Margin-15752.00%
Net Profit Margin-14102.00%
EBITDA Margin-4581.33%
EBIT Margin-6808.00%
Analyst Forecast
The average price target for Impact BioMedical, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―